Michael Yee
Stock Analyst at Jefferies
(2.74)
# 1,862
Out of 4,873 analysts
82
Total ratings
40%
Success rate
7.52%
Average return
Main Sectors:
Stocks Rated by Michael Yee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BPMC Blueprint Medicines | Initiates: Buy | $135 | $128.25 | +5.26% | 1 | Mar 17, 2025 | |
| ALXO ALX Oncology Holdings | Upgrades: Buy | $2 → $3 | $0.46 | +555.45% | 5 | Mar 6, 2025 | |
| CRGX CARGO Therapeutics | Downgrades: Hold | $32 → $3 | $4.14 | -27.54% | 3 | Jan 30, 2025 | |
| KOD Kodiak Sciences | Upgrades: Buy | $20 | $3.69 | +442.01% | 3 | Dec 9, 2024 | |
| BIIB Biogen | Downgrades: Hold | $250 → $180 | $127.31 | +41.39% | 5 | Dec 9, 2024 | |
| VRTX Vertex Pharmaceuticals | Upgrades: Buy | $500 → $550 | $445.82 | +23.37% | 4 | Dec 9, 2024 | |
| AMGN Amgen | Maintains: Buy | $380 | $280.35 | +35.54% | 5 | Nov 12, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $40 → $45 | $14.45 | +211.42% | 2 | Nov 1, 2024 | |
| MRNA Moderna | Maintains: Hold | $65 → $55 | $26.86 | +104.77% | 8 | Oct 15, 2024 | |
| MBX MBX Biosciences | Initiates: Buy | $35 | $11.91 | +193.87% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $11.67 | +242.76% | 1 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $385 | $785.07 | -50.96% | 4 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $1.4 → $10 | $1.88 | +431.91% | 3 | Mar 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $3 | $3.02 | -0.66% | 2 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $30 | $16.76 | +79.00% | 2 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $60 → $20 | $16.19 | +23.53% | 8 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $8 → $20 | $35.81 | -44.15% | 3 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $63 → $75 | $7.63 | +882.96% | 1 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $2.40 | +1,150.00% | 1 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $65 | $32.03 | +102.93% | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $1,875 → $1,125 | $5.71 | +19,602.28% | 2 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 → $30 | $1.01 | +2,870.30% | 4 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $30 | $5.99 | +400.83% | 3 | Feb 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $120 | $17.30 | +593.64% | 2 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $70 → $75 | $20.54 | +265.14% | 2 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $30 | $14.91 | +101.21% | 1 | Sep 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $77 | $13.72 | +461.22% | 2 | Nov 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $105.93 | - | 3 | Jan 26, 2018 |
Blueprint Medicines
Mar 17, 2025
Initiates: Buy
Price Target: $135
Current: $128.25
Upside: +5.26%
ALX Oncology Holdings
Mar 6, 2025
Upgrades: Buy
Price Target: $2 → $3
Current: $0.46
Upside: +555.45%
CARGO Therapeutics
Jan 30, 2025
Downgrades: Hold
Price Target: $32 → $3
Current: $4.14
Upside: -27.54%
Kodiak Sciences
Dec 9, 2024
Upgrades: Buy
Price Target: $20
Current: $3.69
Upside: +442.01%
Biogen
Dec 9, 2024
Downgrades: Hold
Price Target: $250 → $180
Current: $127.31
Upside: +41.39%
Vertex Pharmaceuticals
Dec 9, 2024
Upgrades: Buy
Price Target: $500 → $550
Current: $445.82
Upside: +23.37%
Amgen
Nov 12, 2024
Maintains: Buy
Price Target: $380
Current: $280.35
Upside: +35.54%
Denali Therapeutics
Nov 1, 2024
Maintains: Buy
Price Target: $40 → $45
Current: $14.45
Upside: +211.42%
Moderna
Oct 15, 2024
Maintains: Hold
Price Target: $65 → $55
Current: $26.86
Upside: +104.77%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $35
Current: $11.91
Upside: +193.87%
Sep 13, 2024
Initiates: Buy
Price Target: $40
Current: $11.67
Upside: +242.76%
Jul 17, 2024
Initiates: Buy
Price Target: $385
Current: $785.07
Upside: -50.96%
Mar 27, 2024
Upgrades: Buy
Price Target: $1.4 → $10
Current: $1.88
Upside: +431.91%
Mar 15, 2024
Downgrades: Hold
Price Target: $16 → $3
Current: $3.02
Upside: -0.66%
Dec 8, 2023
Downgrades: Hold
Price Target: $75 → $30
Current: $16.76
Upside: +79.00%
Oct 25, 2023
Downgrades: Hold
Price Target: $60 → $20
Current: $16.19
Upside: +23.53%
Oct 25, 2023
Upgrades: Buy
Price Target: $8 → $20
Current: $35.81
Upside: -44.15%
Jan 6, 2023
Upgrades: Buy
Price Target: $63 → $75
Current: $7.63
Upside: +882.96%
Nov 15, 2021
Initiates: Buy
Price Target: $30
Current: $2.40
Upside: +1,150.00%
Mar 2, 2021
Initiates: Buy
Price Target: $65
Current: $32.03
Upside: +102.93%
Mar 2, 2021
Downgrades: Hold
Price Target: $1,875 → $1,125
Current: $5.71
Upside: +19,602.28%
Feb 12, 2021
Downgrades: Hold
Price Target: $40 → $30
Current: $1.01
Upside: +2,870.30%
Feb 12, 2021
Upgrades: Buy
Price Target: $15 → $30
Current: $5.99
Upside: +400.83%
Nov 6, 2020
Downgrades: Hold
Price Target: $120
Current: $17.30
Upside: +593.64%
Oct 12, 2020
Upgrades: Buy
Price Target: $70 → $75
Current: $20.54
Upside: +265.14%
Sep 14, 2020
Initiates: Buy
Price Target: $30
Current: $14.91
Upside: +101.21%
Nov 8, 2018
Assumes: Buy
Price Target: $77
Current: $13.72
Upside: +461.22%
Jan 26, 2018
Upgrades: Buy
Price Target: n/a
Current: $105.93
Upside: -